Become an Incathlab member and receive full access to its content!
Registration Login
Ablative therapies have been increasingly utilized in the treatment of soft tissue tumors. Irreversible electroporation (IRE) is an energy delivery system, effective in ablating tumors by inducing irreversible membrane destruction of cells.
Over the last few years the technology has been adopted by different medical disciplines via percutaneous or surgical approach with promising clinical outcomes.
In this live webinar you will learn interventional strategies to deal with these patients.
Program (GMT +1)
| 17:00 | Welcome and an introduction to how IRE works - Dr. Anders Nilsson, Interventional Radiologist (Uppsala University Hospital, Uppsala) - Chairman |
| 17:05 | Lecture by Dr. Martijn Meijerink, Interventional Radiologist (VUmc, Amsterdam) - "Percutaneous CT-guided irreversible electroporation (IRE) for locally advanced pancreatic cancer" |
| 17:25 | Lecture by Dr. Paul Ross, Medical Oncologist (King’s College, London) - "Management of locally advanced pancreatic cancer" |
| 17:45 | Lecture by Mr Krish Menon, Surgeon (King’s College, London) - "Clinical value of NanoKnife in pancreatic head cancer from a Surgeon's persepctive" - study results in collaboration with Dr. Praveen Peddu, Radiologist (King’s College, London) |
| 18:05 | Lecture by Dr. Anders Nilsson, Interventional Radiologist (Uppsala University Hospital, Uppsala) - "Needle placement under ultrasound guidance; how to make it work" |
| 18:25 | Global discussion / Q&A session |
| 18:30 | Take home messages and conclusion |
Educational objectives
Provide clinicians with updated information on the use of Irreversible Elelctroporation in the treatment of stage III locally advanced pancreatic cancer. This includes the experience of different medical disciplines such as Interventional Radiologists, Surgeons and Medical Oncologist as well as a review of published clinical data.
Audience
Any international healthcare professional that is part of a pancreatic cancer patient’s care pathway and/or interested in the treatment of stage III locally advanced pancreatic cancer with Irreversible Electroporation.
Publications
- Treatment of 200 Locally Advanced (Stage III) Pancreatic Adenocarcinoma Patients With Irreversible Electroporation: Safety and Efficacy
- Use of irreversible electroporation in unresectable pancreatic cancer
- Irreversible Electroporation (NanoKnife®)
- A Potential Boon for Pancreatic Cancer Patients
Last update : 2018-03-07
Join the Discussion
Suggestions
San Francisco : Thursday, June 18th 2026 from 10am to 11am (GMT+2)
New York : Thursday, June 18th 2026 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, June 18th 2026 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, June 18th 2026 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, June 18th 2026 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, June 18th 2026 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, June 18th 2026 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, June 18th 2026 from 09pm to 10pm (GMT+2)
Bangkok : Friday, June 19th 2026 from 12am to 01am (GMT+2)
Shanghai : Friday, June 19th 2026 from 01am to 02am (GMT+2)
Tokyo : Friday, June 19th 2026 from 02am to 03am (GMT+2)
Sydney : Friday, June 19th 2026 from 04am to 05am (GMT+2)
Wellington : Friday, June 19th 2026 from 06am to 07am (GMT+2)
adnan A. are these IRE pancreas ablations In-situ ablations or for margin enhancement being done at the same time as surgical resection. thx A
Villar J. Question from Dr. Mata (Spain). How many studies are currently on going in resectable pancreatic cancer?
Javad E. It was good. For me the most important aspect was coverage of topic from different points of view . I lost the online webinar for the sake of job matteres but hopefully watched its record finally. Thanks a lot .